Therapeutic agents

Details for Australian Patent Application No. 2003290309 (hide)

Owner AstraZeneca AB

Inventors Minidis, Anna; Olsson, Anna Christina; Aurell, Carl-Johan; Yousefi-Salakdeh, Esmail; Li, Lanna; Lindstedt Alstermark, Eva-Lotte; Dahlstrom, Mikael Ulf Johan

Agent Davies Collison Cave

Pub. Number AU-B-2003290309

PCT Number PCT/GB2003/0056

PCT Pub. Number WO2004/056748

Priority 0229931.1 21.12.02 GB

Filing date 19 December 2003

Wipo publication date 14 July 2004

Acceptance publication date 18 January 2007

International Classifications

C07C 235/20 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 0229931.1 21.12.02 GB

19 August 2004 Application Open to Public Inspection

  Published as AU-B-2003290309

18 January 2007 Application Accepted

  Published as AU-B-2003290309

24 May 2007 Standard Patent Sealed

16 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003290310-CHORIONIC SOMATOMAMMOTROPIN HORMONE SPLICE VARIANTS

2003290308-METHOD AND SYSTEM FOR AVERTING OR MITIGATING UNDESIRABLE DRILLING EVENTS